Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing
Nat Rev Drug Discov
.
2023 Mar;22(3):165-166.
doi: 10.1038/d41573-023-00014-y.
Authors
Francesco Marchetti
,
Renato Cardoso
,
Connie L Chen
,
George R Douglas
,
Joanne Elloway
,
Patricia A Escobar
,
Tod Harper Jr
,
Robert H Heflich
,
Darren Kidd
,
Anthony M Lynch
,
Meagan B Myers
,
Barbara L Parsons
,
Jesse J Salk
,
Raja S Settivari
,
Stephanie L Smith-Roe
,
Kristine L Witt
,
Carole Yauk
,
Robert R Young
,
Shaofei Zhang
,
Sheroy Minocherhomji
PMID:
36646809
DOI:
10.1038/d41573-023-00014-y
No abstract available
Publication types
News
MeSH terms
Carcinogenicity Tests
DNA Damage*
High-Throughput Nucleotide Sequencing*
Humans
Grants and funding
R44 ES030642/ES/NIEHS NIH HHS/United States